Results 161 to 170 of about 20,619 (221)

Skin lesions in patients treated with growth hormone and those with growth hormone excess: a current overview. [PDF]

Front Med (Lausanne)
Matwiejuk M, Myśliwiec H, Miklosz A, Chabowski A, Flisiak I.   +4 more
europepmc   +1 more source

Pathogenesis of nonfamilial somatotroph adenomas.

J Clin Endocrinol Metab
Ben-Shlomo A, Melmed S.
europepmc   +1 more source

Serum Lipidomic Profile Signature of Active Acromegaly and Relationships to Cardiovascular Disease. [PDF]

Int J Mol Sci
Stănoiu-Pînzariu O, Wolters TLC, Socaciu C, Silaghi CA, Valea A, Popa-Ilie I, Hazi G, Socaciu AI, Netea-Maier RT, Georgescu CE.   +9 more
europepmc   +1 more source

Acromegaly-induced dilated cardiomyopathy presenting with heart failure as the cardinal symptom: A case report. [PDF]

SAGE Open Med Case Rep
Xu J, Liu J, Wu H, Zhu X, Hu J.
europepmc   +1 more source

Paltusotine: The first FDA approved oral treatment for acromegaly. [PDF]

Ann Med Surg (Lond)
Faraz B, Sheikh S, Haq MAU, Haider E, Mujahid MUF, Mustafe Hidig S.   +5 more
europepmc   +1 more source

Hormonal staining patterns and clinical outcomes in acromegaly: a 15-year single-center study. [PDF]

Pituitary
Öksüz SBT, Aydemir EE, Heper AO, Ersöz CC, Erdoğan MF, Emral R, Şahin M, Demir Ö, Canpolat AG, Güllü S.   +9 more
europepmc   +1 more source

Diagnostic and prognostic value of myocardial work indices in evaluating cardiac function damage in active acromegaly patients. [PDF]

Endocr Connect
Huang R, Zhang P, He W, Jin J, Peng Y, Li Y, Xiao H, Yao F, Li H.   +8 more
europepmc   +1 more source

Rapid and Sustained Response of Biochemically Uncontrolled Acromegaly to Once-daily Oral Paltusotine Treatment.

J Clin Endocrinol Metab
Biller BMK, Casagrande A, Elenkova A, Boguszewski CL, Jallad RS, Hu B, Hubina E, Fazeli PK, Fleseriu M, Snyder PJ, Strasburger CJ, Bidlingmaier M, Zhao Y, Soares B, Trainer PJ, Struthers RS, Krasner A, Gadelha MR.   +17 more
europepmc   +1 more source

Cost-effectiveness of personalized medical treatment in acromegaly: a post hoc analysis of the ACROFAST study. [PDF]

J Endocr Soc
Marques-Pamies M, Ricou L, Gil J, Sampedro-Núñez M, Biagetti B, Giménez-Palop O, Hernández M, Martínez S, Carrato C, Villar-Taibo R, Araujo-Castro M, Blanco C, Simón-Muela I, Simó-Servat A, Xifra G, Vázquez F, Pavón I, Rosado JA, García-Centeno R, Zavala R, Hanzu FA, Mora M, Aulinas A, Vilarrasa N, Torres A, Librizzi S, Calatayud M, de Miguel Novoa P, Alvarez-Escola C, Picó A, Salinas I, Fajardo-Montañana C, Cámara R, Bernabéu I, Jordà M, Webb SM, Marazuela M, Valassi E, Puig-Domingo M.   +38 more
europepmc   +1 more source

A Medically Managed Case of Acromegaly: A Case Report. [PDF]

Cureus
Bdour K, Al-Sarihin K, El Issa N, Alwraikat O, Albadarneh M, Al-Asa'd R, Alwadi M.   +6 more
europepmc   +1 more source